UNSPSC 85713719: Reposition left carpal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to reposition left carpal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RSR3ZZ

UNSPSC 85713719 Reposition left carpal joint, percutaneous approach is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its nominal clinical scope. The six recent opportunities posted to state and local procurement channels between July and September 2026—including independent medical evaluation services for disability retirement determinations, surgical benefit carve-out programs, occupational medical surveillance, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—do not involve carpal joint repositioning or similar orthopedic surgical procedures. The code appears to be a clinical procedure classification that does not map to the goods and services state and local governments actually contract for through traditional procurement channels.

This code warrants a skip for business development purposes. State and local procurement officers use UNSPSC taxonomy to classify and search for goods and services they purchase, and a Commodity code that carries a specific surgical procedure name will rarely if ever appear in RFP, RFQ, IFB, or ITB notices from state agencies, counties, cities, school districts, or health systems. If state or local procurement officers are acquiring related services—such as orthopedic surgical services through a health provider network, temporary physician staffing, or medical evaluation protocols—they typically tag those opportunities with higher-tier Family or Class codes that span the broader service category rather than a single surgical procedure. The code's current absence from recent opportunities and its clinical nomenclature suggest it has limited relevance to state and local purchasing strategy.